Industry: Chemical & Material
Published Date: 2025-02-15
Pages: 95 Pages
Report ld: 3946710
Request Sample
Customized Report
The global Atractylenolide I market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
The North America Atractylenolide I market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Atractylenolide I include Merck, Selleck Chemicals, Cayman Chemical, AbMole, Biorbyt, BioVision, BOC Sciences, MuseChem, Taiclone, APExBIO Technology, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Atractylenolide I market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atractylenolide I market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Atractylenolide I in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Atractylenolide I manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atractylenolide I revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Atractylenolide I Product Scope
1.2 Atractylenolide I by Type
1.2.1 Global Atractylenolide I Sales by Type (2020 & 2024 & 2031)
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Atractylenolide I by Application
1.3.1 Global Atractylenolide I Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Research
1.3.3 Medical
1.4 Global Atractylenolide I Market Estimates and Forecasts (2020-2031)
1.4.1 Global Atractylenolide I Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Atractylenolide I Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Atractylenolide I Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Atractylenolide I Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Atractylenolide I Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Atractylenolide I Sales Market Share by Region (2020-2025)
2.2.2 Global Atractylenolide I Revenue Market Share by Region (2020-2025)
2.3 Global Atractylenolide I Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Atractylenolide I Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Atractylenolide I Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Atractylenolide I Market Size and Prospective (2020-2031)
2.4.2 Europe Atractylenolide I Market Size and Prospective (2020-2031)
2.4.3 China Atractylenolide I Market Size and Prospective (2020-2031)
2.4.4 Japan Atractylenolide I Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Atractylenolide I Historic Market Review by Type (2020-2025)
3.1.1 Global Atractylenolide I Sales by Type (2020-2025)
3.1.2 Global Atractylenolide I Revenue by Type (2020-2025)
3.1.3 Global Atractylenolide I Price by Type (2020-2025)
3.2 Global Atractylenolide I Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Atractylenolide I Sales Forecast by Type (2026-2031)
3.2.2 Global Atractylenolide I Revenue Forecast by Type (2026-2031)
3.2.3 Global Atractylenolide I Price Forecast by Type (2026-2031)
3.3 Different Types Atractylenolide I Representative Players
4 Global Market Size by Application
4.1 Global Atractylenolide I Historic Market Review by Application (2020-2025)
4.1.1 Global Atractylenolide I Sales by Application (2020-2025)
4.1.2 Global Atractylenolide I Revenue by Application (2020-2025)
4.1.3 Global Atractylenolide I Price by Application (2020-2025)
4.2 Global Atractylenolide I Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Atractylenolide I Sales Forecast by Application (2026-2031)
4.2.2 Global Atractylenolide I Revenue Forecast by Application (2026-2031)
4.2.3 Global Atractylenolide I Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Atractylenolide I Application
5 Competition Landscape by Players
5.1 Global Atractylenolide I Sales by Players (2020-2025)
5.2 Global Top Atractylenolide I Players by Revenue (2020-2025)
5.3 Global Atractylenolide I Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atractylenolide I as of 2024)
5.4 Global Atractylenolide I Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Atractylenolide I, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Atractylenolide I, Product Type & Application
5.7 Global Key Manufacturers of Atractylenolide I, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Atractylenolide I Sales by Company
6.1.1.1 North America Atractylenolide I Sales by Company (2020-2025)
6.1.1.2 North America Atractylenolide I Revenue by Company (2020-2025)
6.1.2 North America Atractylenolide I Sales Breakdown by Type (2020-2025)
6.1.3 North America Atractylenolide I Sales Breakdown by Application (2020-2025)
6.1.4 North America Atractylenolide I Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Atractylenolide I Sales by Company
6.2.1.1 Europe Atractylenolide I Sales by Company (2020-2025)
6.2.1.2 Europe Atractylenolide I Revenue by Company (2020-2025)
6.2.2 Europe Atractylenolide I Sales Breakdown by Type (2020-2025)
6.2.3 Europe Atractylenolide I Sales Breakdown by Application (2020-2025)
6.2.4 Europe Atractylenolide I Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Atractylenolide I Sales by Company
6.3.1.1 China Atractylenolide I Sales by Company (2020-2025)
6.3.1.2 China Atractylenolide I Revenue by Company (2020-2025)
6.3.2 China Atractylenolide I Sales Breakdown by Type (2020-2025)
6.3.3 China Atractylenolide I Sales Breakdown by Application (2020-2025)
6.3.4 China Atractylenolide I Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Atractylenolide I Sales by Company
6.4.1.1 Japan Atractylenolide I Sales by Company (2020-2025)
6.4.1.2 Japan Atractylenolide I Revenue by Company (2020-2025)
6.4.2 Japan Atractylenolide I Sales Breakdown by Type (2020-2025)
6.4.3 Japan Atractylenolide I Sales Breakdown by Application (2020-2025)
6.4.4 Japan Atractylenolide I Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Business Overview
7.1.3 Merck Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Merck Atractylenolide I Products Offered
7.1.5 Merck Recent Development
7.2 Selleck Chemicals
7.2.1 Selleck Chemicals Company Information
7.2.2 Selleck Chemicals Business Overview
7.2.3 Selleck Chemicals Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Selleck Chemicals Atractylenolide I Products Offered
7.2.5 Selleck Chemicals Recent Development
7.3 Cayman Chemical
7.3.1 Cayman Chemical Company Information
7.3.2 Cayman Chemical Business Overview
7.3.3 Cayman Chemical Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Cayman Chemical Atractylenolide I Products Offered
7.3.5 Cayman Chemical Recent Development
7.4 AbMole
7.4.1 AbMole Company Information
7.4.2 AbMole Business Overview
7.4.3 AbMole Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AbMole Atractylenolide I Products Offered
7.4.5 AbMole Recent Development
7.5 Biorbyt
7.5.1 Biorbyt Company Information
7.5.2 Biorbyt Business Overview
7.5.3 Biorbyt Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Biorbyt Atractylenolide I Products Offered
7.5.5 Biorbyt Recent Development
7.6 BioVision
7.6.1 BioVision Company Information
7.6.2 BioVision Business Overview
7.6.3 BioVision Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.6.4 BioVision Atractylenolide I Products Offered
7.6.5 BioVision Recent Development
7.7 BOC Sciences
7.7.1 BOC Sciences Company Information
7.7.2 BOC Sciences Business Overview
7.7.3 BOC Sciences Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.7.4 BOC Sciences Atractylenolide I Products Offered
7.7.5 BOC Sciences Recent Development
7.8 MuseChem
7.8.1 MuseChem Company Information
7.8.2 MuseChem Business Overview
7.8.3 MuseChem Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.8.4 MuseChem Atractylenolide I Products Offered
7.8.5 MuseChem Recent Development
7.9 Taiclone
7.9.1 Taiclone Company Information
7.9.2 Taiclone Business Overview
7.9.3 Taiclone Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Taiclone Atractylenolide I Products Offered
7.9.5 Taiclone Recent Development
7.10 APExBIO Technology
7.10.1 APExBIO Technology Company Information
7.10.2 APExBIO Technology Business Overview
7.10.3 APExBIO Technology Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.10.4 APExBIO Technology Atractylenolide I Products Offered
7.10.5 APExBIO Technology Recent Development
7.11 J&K Scientific
7.11.1 J&K Scientific Company Information
7.11.2 J&K Scientific Business Overview
7.11.3 J&K Scientific Atractylenolide I Sales, Revenue and Gross Margin (2020-2025)
7.11.4 J&K Scientific Atractylenolide I Products Offered
7.11.5 J&K Scientific Recent Development
8 Atractylenolide I Manufacturing Cost Analysis
8.1 Atractylenolide I Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Atractylenolide I
8.4 Atractylenolide I Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Atractylenolide I Distributors List
9.3 Atractylenolide I Customers
10 Atractylenolide I Market Dynamics
10.1 Atractylenolide I Industry Trends
10.2 Atractylenolide I Market Drivers
10.3 Atractylenolide I Market Challenges
10.4 Atractylenolide I Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Atractylenolide I was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 142
USD 3950.00
(Single User License)
The global Atractylenolide I market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 139
USD 2900.00
(Single User License)
The global Atractylenolide I market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 156
USD 4900.00
(Single User License)
The global market for Atractylenolide I was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 120
USD 3950.00
(Single User License)
The global market for Atractylenolide I was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 97
USD 2900.00
(Single User License)
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published Date: 2024-02-19
Pages: 120
USD 3950.00
(Single User License)
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published Date: 2024-01-12
Pages: 104
USD 2900.00
(Single User License)
The global market for Atractylenolide I was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 142
The global Atractylenolide I market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 139
The global Atractylenolide I market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 156
The global market for Atractylenolide I was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 120
The global market for Atractylenolide I was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 97
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published: 2024-04-07
Pages: 108
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published: 2024-02-19
Pages: 120
Atractylenolide I is a sesquiterpene that has been found in the rhizomes of A. macrocephala and has diverse biological activities, including anti-inflammatory, anti-angiogenic, anti-tumor, and antidepressant properties.
Published: 2024-01-12
Pages: 104
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now